The Testosterone Trials in Older Men

PHASE3CompletedINTERVENTIONAL
Enrollment

790

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2018

Conditions
Andropause
Interventions
DRUG

AndroGel® (testosterone gel)

Testosterone levels will be measured at regular intervals in order to achieve a testosterone level in the desired range.

DRUG

Placebo

Testosterone levels will be measured at regular intervals.

Trial Locations (12)

10461

Albert Einstein College of Medicine, The Bronx

15261

University of Pittsburgh, Pittsburgh

32611

University of Florida, Gainesville

35294

University of Alabama at Birmingham, Birmingham

55455

University of Minnesota, Minneapolis

60208

Northwestern University, Chicago

76798

Baylor College of Medicine, Houston

90501

Center for Men's Health LA BioMed at Harbor-UCLA Medical Center, Torrance

92093

University of California San Diego, La Jolla

98108

VA Puget Sound Health Care System, Seattle

06520

Yale University, New Haven

02215

Boston University, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Abbott

INDUSTRY

lead

University of Pennsylvania

OTHER